Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate specific antigen. Experimental and clinical observations.

P R Huber1, Y Schnell, F Hering

  • 1Department of Gynecology, University Hospital, Basel, Switzerland.

Scandinavian Journal of Urology and Nephrology. Supplementum
|January 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medical considerations in the certification of civil airmen.

The Journal of aviation medicine·2010
Same author

[Testicular toxoplasmosis: a rare case of a testicular mass].

Actas urologicas espanolas·2008
Same author

Natural rubber latex sensitisation and allergy in patients with spina bifida, urogenital disorders and oesophageal atresia compared with a normal paediatric population.

European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie·2007
Same author

Value of gonadotropin-releasing hormone testing in the differential diagnosis of androgen deficiency in elderly men.

The Journal of clinical endocrinology and metabolism·2004
Same author

Use of bisphosphonates can dramatically improve pain in advanced hormone-refractory prostate cancer patients.

Prostate cancer and prostatic diseases·2004
Same author

Capecitabine in hormone-resistant metastatic prostatic carcinoma - a phase II trial.

British journal of cancer·2004
Same journal

Bladder cancer-from pathogenesis to prevention, 2008. Proceedings of an international consultation organized by the WHO Collaborating Center for Urologic Tumors. April 24-25, 2008. Stockholm, Sweden.

Scandinavian journal of urology and nephrology. Supplementum·2009
Same journal

The global burden of urinary bladder cancer.

Scandinavian journal of urology and nephrology. Supplementum·2008
Same journal

Bladder cancer: chemoprevention, complementary approaches and budgetary considerations.

Scandinavian journal of urology and nephrology. Supplementum·2008
Same journal

Screening for bladder cancer: theoretical and practical issues in considering the treated and untreated natural history of the various forms of the disease.

Scandinavian journal of urology and nephrology. Supplementum·2008
Same journal

Combining a molecular profile with a clinical and pathological profile: biostatistical considerations.

Scandinavian journal of urology and nephrology. Supplementum·2008
Same journal

How to combine the molecular profile with the clinicopathological profile of urothelial neoplastic lesions.

Scandinavian journal of urology and nephrology. Supplementum·2008
See all related articles

Prostate specific antigen (PSA) is a reliable marker for early prostate cancer detection. This study confirms PSA

Area of Science:

  • Urology
  • Oncology
  • Biochemistry

Background:

  • Prostate specific antigen (PSA) is a protein produced by cells of the prostate gland.
  • Elevated serum PSA levels are associated with prostate cancer, but also with benign prostatic hyperplasia (BPH).
  • Accurate diagnostic tools are crucial for differentiating prostate cancer from benign conditions.

Purpose of the Study:

  • To evaluate the analytical specificity and clinical applicability of a commercial radioimmunoassay (RIA) for PSA.
  • To assess the utility of serum PSA as a screening method for early prostate cancer detection.

Main Methods:

  • Investigated the immunochemical identity of PSA in serum and seminal plasma.
  • Analyzed PSA's protein characteristics using isoelectric focusing and denaturing electrophoresis.

Related Experiment Videos

  • Assessed serum PSA levels in patients with BPH and early-stage prostate cancer (T0/T1) compared to a healthy control group.

    • Main Results:

    • Serum PSA is immunochemically identical to seminal plasma PSA and exists as a group of isoproteins.
    • Serum PSA is stable at room temperature, unlike prostatic acid phosphatase (PAP).
    • Patients with BPH showed PSA levels comparable to controls, while early prostate cancer cases exhibited higher PSA ranges (7.7-12.2 ng/ml), correlating with tumor volume.

    Conclusions:

    • The commercial RIA for PSA demonstrates analytical specificity and clinical relevance for prostate cancer diagnosis.
    • Serum PSA can differentiate between early prostate cancer and BPH, suggesting its potential as a screening tool.
    • PSA levels correlate with tumor volume, aiding in the distinction of early-stage prostate carcinomas.